Comparison of Different Up-dosing Schedules With Osiris.

Trial Profile

Comparison of Different Up-dosing Schedules With Osiris.

Phase of Trial: Phase II

Latest Information Update: 26 Aug 2011

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Allergic rhinitis; Grass pollen hypersensitivity
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors ALK-Abello
  • Most Recent Events

    • 26 Aug 2011 Status changed from not yet recruiting to discontinued as reported by
    • 11 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top